Powerful Medical

Home
Slovakia
Bratislava
Powerful Medical

Powerful Medical is a deep-tech company, tackling the most challenging problems of modern medicine using artificial intelligence and machine learning.

12/04/2026

3 reasons AI is changing how we treat heart attacks 🫀

We asked Dr. Timothy D. Henry — founder of the first primary PCI Network in the US — where he sees the biggest opportunities for AI in heart attack care.

✅ Fewer false cath lab activations
✅ Faster diagnosis of borderline STEMIs (STEMI equivalents)
✅ Better care at rural & non-PCI hospitals — where only 17% of patients get treated on time

09/04/2026

New peer-reviewed evidence on PMcardio’s Queen of Hearts, including two publications, highlights a meaningful opportunity to improve acute coronary syndrome care.

Across four studies published in March 2026, spanning more than 3,000 patients and five U.S. health systems, a consistent finding emerges: a substantial proportion of occlusive myocardial infarctions (OMI) are not captured by standard-of-care criteria, leading to delays of up to 7 hours to life-saving coronary angiography. These patients face higher in-hospital and long-term mortality.

In multicenter and real-world settings, AI ECG analysis demonstrates strong performance in identifying acute coronary occlusion, even in the absence of traditional criteria, with high sensitivity, specificity, and predictive value. This has the potential to significantly accelerate access to life-saving care.

We thank all collaborators and clinical partners for their contributions to these important studies.

We also thank the for supporting part of this research through a Quality Initiative/Process Improvement grant.

27/03/2026

We’re excited to share that Powerful Medical will be participating in ACC.26 in New Orleans.
Our team will be presenting 2 scientific presentations at one of the world’s leading cardiology meetings.
We’re looking forward to meeting fellow clinicians, partners, and innovators at ACC.26. See you in New Orleans.

25/03/2026

AI outperforms conventional diagnosis for certain types of heart attacks

We’re proud to see this important prospective study of 1,490 suspected NSTE-ACS patients led by Matthias Unterhuber and Federico Nani at Bolzano Hospital featured by the European Society of Cardiology at the conference.

The findings highlight the potential of Queen of Hearts AI-enabled ECG interpretation to improve detection of occlusive myocardial infarction (OMI) in patients without ST elevation, a group in which rapid and accurate diagnosis remains especially challenging. AI achieved 77% sensitivity, compared to 42% with standard ECG interpretation, alongside 99% specificity.

This is how AI can play a meaningful role in acute cardiovascular care, supporting clinicians with faster, more precise decision-making and enabling earlier, life-saving treatment.

Read more in the ESC press release, link in comments

16/03/2026

🎯 Patient enrollment completed for the AI ECG TIMI Study

We are proud to announce the completion of patient enrollment in the AI ECG TIMI Study, enrolling 709 heart attack patients across 9 centers in 3 countries to evaluate how -powered ECG interpretation can aid in the diagnosis of occlusive myocardial infarction.

Here is why the AI ECG TIMI study will provide important insights for the new acute myocardial infarction paradigm:

• All-comer ACS population (STEMI, NSTEMI, MINOCA, and unstable angina)
• ECGs collected at 4 standardized timepoints (before, during, after PCI)
• Core-lab adjudicated coronary angiograms, including advanced vessel and myocardial blush grade assessment

A big congratulations to the top enrolling sites: , , and .cardiologia.sanpietro.roma!

And a sincere thank you to all participating sites, investigators, coordinators, and patients who made this milestone possible. Your dedication is essential for advancing the evidence base for improving heart attack care.

This study has been co-funded by the EIC - European Innovation Council within the HORIZON-EIC-2023 call.

11/02/2026

Last night in Aalst, we had the pleasure of presenting PMcardio and the impact our AI-enabled STEMI pathway is already having to a room of ~60 general practitioners during their New Year reception 👩‍⚕️
The engagement was fantastic, and there was strong interest in how AI-supported workflows can accelerate the recognition of acute cardiac events and support clinicians in time-critical decision-making.
A big thank you to the organizers for a well-run, energizing event, and congratulations to the physicians recognized during the evening’s awards.
Over the past year, 70 GPs have been using PMcardio in the Aalst region—and last night we saw that community grow further, with many more requesting access after the session 💙

10/02/2026

Last week Martin Herman, our co-founder and CEO at Powerful Medical, took the stage to discuss Investments in AI.
The event was organized by SASK and moderated by Michaela Krskova, Board Member at European Innovation Council. Thank you for having us!

05/02/2026

Another milestone in Slovakia 🇸🇰
In January, we successfully onboarded another Primary PCI center — KC Nitra.

KC Nitra treats ~800 STEMI cases per year, which is an impressive number—about 2–3× more than other similarly sized PCI centers. We had over 25 participants join our onboarding session, with great engagement throughout and plenty of practical, hands-on questions. Huge thanks to everyone involved for making it run so smoothly.

With this onboarding, PMcardio is now active in six Primary PCI centers in Slovakia, meaning ~75% of STEMI patients nationwide can already benefit from our technology.

02/02/2026

Swipe for our 2025 review →

In 2025, PMcardio helped teams act faster when time matters:
• 1,231,997 ECGs analyzed
• 124,298 heart attacks detected (including STEMI equivalents)
• 9,767 lives prolonged

Thank you to our clinical partners and everyone supporting Powerful Medical. Together, we’re assisting earlier recognition of the acute coronary syndrome and timely triage decisions.

In 2026, we’re doubling down on making these time-critical decisions accessible to even more teams and patients.

06/12/2025

👋🏼 Privítajte nášho decembrového hosťa na tému Innovation! 🎤

Viktor Jurášek je produktový riaditeľ a spoluzakladateľ Powerful Medical . S tímom stojí za PMcardio – AI platformou na diagnostiku a manažment pacientov s ochoreniami srdca, používanou tisíckami lekárov po celom svete. PMcardio dokáže z bežného EKG v sekundách rozpoznať infarkt a desiatky ďalších diagnóz. Po viac než dekáde v produktovom a digitálnom dizajne prepája softvér, dátovú vedu a klinickú prax do riešení, ktoré lekárom uľahčujú rozhodovanie v prostredí, kde sekundy rozhodujú o živote. Verí, že skutočné inovácie vznikajú až v momente, keď sa špičková technológia stretne s jednoduchou použiteľnosťou a dôverou používateľov.
Pred spoluzaložením Powerful Medical stál pri zrode viacerých platforiem v zdravotníctve a softvéri. Jeho cieľom sú inovácie, ktoré sa premietnu do lepšej starostlivosti o pacienta.

👋🏼 Welcome our december speaker! 🎤
Viktor Jurasek is the Chief Product Officer and Co-Founder of Powerful Medical. He leads PMcardio – an AI platform for diagnostics and management of cardiac patients, used by thousands of clinicians worldwide. PMcardio can recognize a heart attack and dozens of other diagnoses from a standard ECG within seconds. With over a decade of experience in product and digital design, he bridges software, data science, and clinical practice into solutions that help clinicians make decisions in environments where seconds truly matter. He believes real innovation happens when cutting-edge technology meets simple usability and genuine user trust. Before co-founding Powerful Medical, he helped launch several platforms in healthcare and software. His goal is to drive innovations that translate into better patient care.

03/12/2025

🚀 Full Site Activation + 500 Patients Enrolled!

We’re excited to announce two major milestones for the AI-ECG TIMI study:

✅ 100% site activation across all participating countries
📈 500 patients enrolled toward our target of 709 subjects

The AI-ECG TIMI study is an international, multi-center observational study designed to validate how AI can improve the detection and management of acute coronary syndrome. By correlating coronary vessel status with 12-lead ECGs, it aims to transform real-time diagnosis and clinical decision-making in cardiovascular care.

A big thank you to all investigators, clinical sites, and partners for driving this momentum forward. Onward! 🚀

Rede Optimus

Address

Bratislava

Website

http://powerfulmedical.com/

Alerts

Be the first to know and let us send you an email when Powerful Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Powerful Medical:

Shortcuts

Want your practice to be the top-listed Clinic in Bratislava?